Kristen Mueller

Title: Kristen Mueller: Innovator in Pharmaceutical Compounds

Introduction

Kristen Mueller is a notable inventor based in Saint Paul, MN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address chronic inflammatory diseases. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving healthcare.

Latest Patents

Kristen holds a patent for her invention titled "1,4-Disubstituted benzo-fused compounds." This patent discloses novel 1,4-disubstituted benzo-fused compounds, wherein G, X, L, Q, n, and Y are defined. The compounds are particularly useful in pharmaceutical compositions for treating diseases or pathological conditions involving inflammation, such as chronic inflammatory diseases. Additionally, the patent outlines processes for making these compounds, highlighting their potential impact on medical treatments.

Career Highlights

Kristen is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at this esteemed company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical innovation.

Collaborations

Some of her coworkers include Pier Francesco and Daniel R Goldberg, who work alongside her in the pursuit of groundbreaking pharmaceutical solutions. Their collaborative efforts contribute to the success of their projects and the advancement of medical science.

Conclusion

Kristen Mueller is a pioneering inventor whose work in pharmaceutical compounds has the potential to transform treatments for chronic inflammatory diseases. Her dedication to innovation and collaboration within the industry underscores her importance as a leading figure in the field.